Neurogene has reported encouraging efficacy results with its gene therapy for rare genetic disorder Rett syndrome, but ...

Merck KGaA is shaping up to take on Daiichi Sankyo and Ono Pharma in the market for tenosynovial giant cell tumour (TGCT) ...

It came as AZ reported its third-quarter results, headlined by a 20% increase in revenues to $12.95 billion, which will be ...

A new generic version of varenicline – originally sold in the UK as Champix by Pfizer – has now been approved for use by the ...

23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and ...

The new FAIR guidelines aim to help pharma realise the full potential of data. As the amount of data available to pharmaceutical companies continues to accelerate at a rapid pace, it is becoming ...

In our marketing excellence focus month, Kevin Dolgin compares the role of a sales rep in the financial industry with the pharmaceutical industry. In particular, Kevin looks at how customer-facing ...

Both these factors can be tied in part to J&J’s strong presence in the consumer sector – but behind household name products is a strong pharmaceutical backbone that has emerged over the ...

Doug Paul was asked by Siren Interactive to write the fourth of five articles discussing rare disease and orphan drug issues. Pricing is one of the biggest challenges for any pharma company at the ...

The past two years have shone a spotlight on the UK life sciences industry. Pharma companies are now household names, having been thrust into the public’s consciousness after dominating the ...

Life sciences marketing has rapidly evolved to mirror that of consumer retail. There are now more ways than ever to interact with customers, from traditional channels like email and phone calls to ...

Anita Osborn outlines the best ways to start and maintain a patient support initiative in an increasingly complex health environment. As the healthcare environment continues to evolve, patient ...